24
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Hepatobiliary Changes in Patients with Ulcerative Colitis, with Special Reference to the Effect of Proctocolectomy

Pages 113-117 | Published online: 08 Jul 2009

References

  • Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55: 401–12.
  • Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnosis in ulcerative colitis: An epidemiological study. Am J Gastroenterol 1990;85:711–6.
  • Truelove SC. Medical management of ulcerative colitis and indications for colectomy. World J Surg 1988;12:142–7.
  • Perrett AD, Higgins G, Johnston HH, Massarella GR, Truelove SC, Wright R. The liver in ulcerative colitis. Q J Med 1971;158: 211–38.
  • Dew MJ, Thompson H, Allan RN. The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med 1979;189: 113–35.
  • Shepherd HA, Selby WS, Chapman RGW, Nolan D, Barbatis S, McGee J, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983;208:503–13.
  • Wewer V, Gluud C, Schlichting P, Burcharth F, Binder V. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1991;26:97–102.
  • Aitola P, Karvonen A-L, Matikainen M. Prevalence of hepatobiliary dysfunction in patients with ulcerative colitis. Ann Chir Gynecol 1994;83:275–8.
  • Broomé U, Glaumann H, Hellers G, Nilsson B, Sörstad J, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow-up study in the county of Stockholm. Gut 1994;35:84–9.
  • Broome U, Glaumann H, Hultcrantz R. Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990;31: 468–72.
  • Eade MN. Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy. Ann Intern Med 1970;72:475–87.
  • Dordal E, Glagov S, Kirsner JB. Hepatic lesions in chronic inflammatory bowel disease. Gastroenterology 1967;52:239–53.
  • Mattila J, Aitola P, Matikainen M. Liver lesions found at colectomy in ulcerative colitis: correlation between histological findings and biochemical parameters. J Clin Pathol 1994;47: 1019–21.
  • Thomas CH. Ulceration of the colon with a much enlarged fatty liver. Trans Pathol Soc Phila 1873;4:87–8.
  • Tulikoura I, Huikuri K. Morphological fatty changes and function of the liver, serum free fatty acids and triglycerides during parenteral nutrition. Scand J Gastroenterol 1982;17:177–85.
  • Bengoa JM, Hanauer SB, Sitrin MD, Baker AL, Rosenberg IH. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 1985;5:79–84.
  • Hultcrantz R, Glaumann H, Lindberg G, Nilsson l. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109–13.
  • Dombal FT, Goldie W, Watts J, Goligher JC. Hepatic histological changes in ulcerative colitis. Scand J Gastroenterol 1966;1:220–7.
  • Kleckner MS, Stauffer MH, Dockerty MB. Hepatic lesions in the living patient with chronic ulcerative colitis as demonstrated by needle biopsy. Gastroenterology 1952;22:13–33.
  • Palmer WL, Kirsner JB, Goldgraber MB, Fuentes SS. Disease of the liver in chronic ulcerative colitis. Am J Med 1964;36:856–66.
  • Eade MN, Cooke WT, Brooke BN. Liver disease in ulcerative colitis. II. The long-term effect of colectomy. Ann Intern Med 1970;72:489–97.
  • Aitola P, Mattila J, Halonen P, Matikainen M. The effect of colectomy on histological and biochemical liver changes associated with ulcerative colitis. Eur J Gastroenterol Hepatol 1994;6:803–7.
  • Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714–9.
  • Popper H, Schaffer F. Nonspecific reactive hepatitis. In: Popper H, Schaffer F, editors. Liver: structure and function. New York: McGraw-Hill; 1957. p. 404–7.
  • MacSween RNM. Liver pathology associated with diseases of other organs: non-specific reactive hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. New York: Churchill Livingstone; 1987. p. 646–8.
  • Mattila J, Pitkänen R, Halonen P, Matikainen M. Ultrastructural aspects of liver injury with special reference to small bile ducts in patients with ulcerative colitis. Liver 1992;12:155–60.
  • Zuckerman MJ, Watts MT. Intestinal permeability to 51Cr-ethylenediaminetetraacetate in patients with ulcerative colitis. Am J Gastroenterol 1993;88:1978–9.
  • Aitola P, Soppi E, Halonen P, Laine S, Matikainen M. The effect of proctocolectomy on serum antibody levels against cow’s milk proteins in patients with chronic ulcerative colitis with special reference to liver changes. Scand J Gastroenterol 1994;29:646–50.
  • Vinnik EI, Kern F. Biliary cirrhosis in a patient with chronic ulcerative colitis. Gastroenterology 1963;45:529–34.
  • Mistilis SP. Pericholangitis and ulcerative colitis. I. Pathology, etiology and pathogenesis. Ann Intern Med 1965;63:1–16.
  • Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 1985;102:581–7.
  • Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980;15:689–97.
  • Rasmussen HH, Fallingborg J, Mortensen PB, Freund L, Tage-Jensen U, Kruse V, et al. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol 1992;27: 732–6.
  • Olsson R, Danielsson Å, Järnerot G, Lindström E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319–23.
  • Chapman RWG, Arborgh BÅM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21: 870–7.
  • Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655–64.
  • Stockbrügger RW, Olsson R, Jaup B, Jensen J. Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterol 1988;35:289–94.
  • Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31–9.
  • Broome U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Col Rectum 1995;38:1301–5.
  • Eade MN, Brooke BN. Portal bacteremia in cases of ulcerative colitis submitted to colectomy. Lancet 1969;1:1008–9.
  • Palmer KR, Duerden BI, Holdsworth CD. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 1980;21:851–4.
  • Brand HS, Maas MAW, Bosma A, Van Ketel RJ, Speelman P, Chamuleau RAFM. Experimental colitis in rats induces low- grade endotoxinemia without hepatobiliary abnormalities. Dig Dis Sci 1994;39:1210–5.
  • Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991;100:1385–91.
  • Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657–62.
  • Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990;98:464–9.
  • Das KM, Squillante L, Chitayet D, Kalousek DK. Simultaneous appearance of a unique common epitope in fetal colon, skin, and biliary epithelial cells. A possible link for extracolonic manifestations in ulcerative colitis. J Clin Gastroenterol 1992;15: 311–6.
  • Mandal A, Dasgupta A, Jefers L, Squillante L, Hyder S, Reddy R, et al. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994;106:185–92.
  • Stauffer MH, Sauer WG, Dearing WH, Baggenstoss AH. The spectrum of cholestatic hepatic disease. JAMA 1965;191:829–37.
  • Wood RAB, Cuschieri A. Is sclerosing cholangitis complicating ulcerative colitis a reversible condition? Lancet 1980;2:716–8.
  • Cangemi JR, Wiesner RH, Beaver SJ, Ludwig J, MacCarty RL, Dozois RR, et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 1989;96:790–4.
  • Shepherd HA, Selby WS, Chapman RGW, Noman D, Barbatis S, McGee J, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983;208:503–13.
  • Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200–6.
  • Mikkola K, Kiviluoto T, Riihelä M, Taavitsainen M, Järvinen HJ. Liver involvement and its course in patients operated on for ulcerative colitis. Hepatogastroenterol 1995;42:68–72.
  • Chapman RWG, Burroughs AK, Bass NM, Sherlock S. Longstanding asymptomatic primary sclerosing cholangitis. Dig Dis Sci 1981;26:778–82.
  • Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1988;95:1395–8.
  • Clements D, Rhodes JM, Elias E. Severe bile duct lesions without biochemical evidence of cholestasis in a case of sclerosing cholangitis. Hepatology 1986;3:72–4.
  • Olsson R, Hultén L. Concurrence of ulcerative colitis and chronic active hepatitis. Clinical course and results of colectomy. Scand J Gastroenterol 1975;10:331–5.
  • Kato Y, Morimoto H, Unoura M, Kobayashi K, Hattori N, Nakanuma Y. Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis. J Clin Gastroenterol 1985; 7:425–7.
  • Bush A, Mitchison H, Walt R, Baron JH, Boylston AW, Summerfield JA. Primary biliary cirrhosis and ulcerative colitis. Gastroenterology 1987;92:2009–13.
  • Oudkerk Pool MO, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BME, Pena AS, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993;34:45–50.
  • Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33: 668–74.
  • Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic autoantibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 1996;38:384–9.
  • Pokorny CS, Norton ID, McCaughan GW, Selby WS. Antineutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994;9: 40–4.
  • Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Gastroenterology 1991;100:1590–6.
  • Reumaux D, Colombel JF, Duclos B, Chaussade S, Belaiche J, Jacquot S, et al. Antineutrophil cytoplasmic auto-antibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis. Adv Exp Med Biol 1993;336:523–5.
  • Patel RT, Stokes R, Birch D, ibbotson J, Keighley MRB. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br J Surg 1994; 81:724–6.
  • Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E. The effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J Clin Pathol 1995;48:645–7.
  • Haagsma EB, Mulder AH, Gouw AS, Horst G, Meerman L, Slooff MJ, et al. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1993;19:8–14.
  • Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995;90:740–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.